Unit Converter
Androstenedione

SI UNITS (recommended)

CONVENTIONAL UNITS

(Δ4-Androstenedione - Adrenal & Gonadal Steroid Precursor)

Synonyms

  • Androstenedione
  • Δ4-Androstenedione
  • ASD
  • Androst-4-ene-3,17-dione
  • Steroid precursor of testosterone & estrone

Units of Measurement

nmol/L, ng/mL, ng/dL, ng/100mL, ng%, ng/L, µg/L
(Most common: ng/dL or nmol/L via LC-MS/MS.)

Description

Androstenedione is an adrenal and gonadal steroid hormone that serves as a precursor to:

  • Testosterone
  • Estrone
  • Estradiol

It is produced by:

  • Adrenal zona reticularis
  • Ovaries (theca cells)
  • Testes (Leydig cells)

Androstenedione measurement is essential in evaluating:

  • Polycystic ovary syndrome (PCOS)
  • Congenital adrenal hyperplasia (CAH)
  • Adrenal tumors
  • Androgen-secreting ovarian tumors
  • Hyperandrogenism in females
  • Early puberty or virilization

Physiological Role

  • Precursor of testosterone and estrogens
  • Produced mainly under control of ACTH
  • Reflects adrenal androgen production
  • In ovaries: produced by LH-stimulated theca cells
  • Mild diurnal variation (morning higher)

Clinical Significance

Elevated Androstenedione

Seen in:

1. Polycystic Ovary Syndrome (PCOS)

  • Mild to moderate elevation
  • Reflects increased ovarian theca activity

2. Congenital Adrenal Hyperplasia (CAH)

Especially:

  • 21-hydroxylase deficiency (most common)
  • 11β-hydroxylase deficiency
  • 3β-HSD deficiency

Levels may be markedly elevated.

3. Adrenal Tumors

  • Adrenocortical carcinoma
  • Adrenal adenomas
  • Very high levels (>1000–2000 ng/dL)

4. Ovarian Tumors

  • Sertoli-Leydig tumors
  • Granulosa-theca cell tumors

5. Premature Adrenarche

  • Early rise in adrenal androgens in children

6. Severe Insulin Resistance

  • Hyperinsulinemia stimulates ovarian theca production

Low Androstenedione

Seen in:

  • Primary adrenal insufficiency (Addison disease)
  • Hypopituitarism (low ACTH)
  • Certain enzyme defects (17α-OH deficiency)
  • Androgen-suppressing medications

Low levels have limited clinical significance compared to elevated levels.

Reference Intervals

(Based on Tietz 8E + ESAP 2024 + Mayo Clinic LC-MS/MS)
Values vary by age, sex, and Tanner stage.

Adult Females

  • 0.7 – 3.1 ng/mL
  • 70 – 310 ng/dL
  • 2.4 – 11 nmol/L

Adult Males

  • 0.6 – 3.1 ng/mL
  • 60 – 310 ng/dL
  • 2.1 – 11 nmol/L

Postmenopausal Women

  • 0.3 – 1.4 ng/mL

Children

  • Very age-dependent
  • Rises during adrenarche (age 6–8 years)

In PCOS

  • Often 1.5–2× upper limit
  • Higher values suggest CAH or tumor

Unit Meanings

UnitMeaning
nmol/Lnanomole per liter
ng/mLnanogram per milliliter
ng/dLnanogram per deciliter
ng/100mLsame as ng%
ng%nanogram per 100 mL
ng/Lnanogram per liter
µg/Lmicrogram per liter (= ng/mL × 1000)

Diagnostic Uses

1. PCOS Evaluation

  • Supports diagnosis in hyperandrogenic women
  • Combined with testosterone & DHEAS

2. CAH Diagnosis & Monitoring

  • Androstenedione increases when 21-OH/11β-OH pathways are blocked

3. Adrenal or Ovarian Tumors

  • Markedly high androstenedione → tumor work-up needed

4. Hirsutism & Virilization Work-Up

Useful with:

  • Testosterone
  • DHEA-S
  • 17-OHP
  • LH/FSH

5. Early Puberty (Adrenarche)

Differentiates:

  • Central puberty
  • Peripheral androgen excess

Analytical Notes

  • Best measured by LC–MS/MS for accuracy
  • Immunoassays may overestimate at low levels
  • Morning sampling preferred
  • Avoid biotin supplements for 12–24 hours before testing
  • Hemolysis has minimal effect

Clinical Pearls

  • In PCOS: androstenedione may be more sensitive than testosterone.
  • Very high levels (>300–500 ng/dL) → think CAH or tumor, not PCOS.
  • DHEAS disproportionately high → adrenal source;
    Androstenedione + testosterone high → ovarian source.
  • In CAH monitoring: androstenedione & 17-OHP used together.
  • Postmenopausal women normally have very low values—mild rise can be significant.

Interesting Fact

Before testosterone assays were perfected, androstenedione was often used as an early biomarker of androgen excess due to its more stable serum concentration.

References

  1. Tietz Clinical Chemistry and Molecular Diagnostics, 8th Edition - Steroid Hormone Section.
  2. ESAP 2024 - Endocrine Reference Ranges.
  3. Mayo Clinic Laboratories - Androstenedione (LC-MS/MS).
  4. ARUP Consult - Hyperandrogenism & CAH Testing.
  5. Endocrine Society PCOS Guidelines.
  6. NIH / MedlinePlus - Androstenedione Overview.
  7. IFCC Steroid Measurement Standards.

Last updated: January 26, 2026

Reviewed by : Medical Review Board

Change language

Other Convertors